Peter Libby and Team Reveal Causal Proteomic Links in Clonal Hematopoiesis
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, posted on LinkedIn:
”Causal Proteomic Consequences of Clonal Hematopoiesis: Integrated Human Genetic and Murine Validation
Zhi Yu, Amelie Vromman…Art Schuermans…Thiago Rentz Ferreira Laginski… Abhishek Niroula…Michael C. Honigberg, Amy E. Lin …Sara Haidermota…Benjamin Ebert…Alexander G. Bick, Siddhartha Jaiswal, Robert E. Gerszten, Peter Libby, Rajat Gupta, Pradeep Natarajan
Presented elegantly today at AHA New Orleans by Zhi Yu, the results of an amazing collaboration on CHIP proteomics that provide new insights and generate novel mechanistic hypotheses regarding the manifold clinical consequences of this newly recognized risk factor.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 13:38Denis Oduor: The Role of Expectant Fathers in Saving Mothers and Newborns
-
Jun 4, 2026, 13:36Mohammad Reza Moghaddasnejad: Platelet Activation as a Key Driver of Breast Cancer Progression
-
Jun 4, 2026, 13:31Fredrick Chalinga: Microcytic Anemia Does Not Always Mean Iron Deficiency
-
Jun 4, 2026, 13:23How Access to Care Changed One Life – WFH
-
Jun 4, 2026, 13:16Muhammad Usman Arshad: Meta-Analysis Supports Expanding Role of DOACs in Cancer-Associated Thromboembolism
-
Jun 4, 2026, 12:59Dual Prognostic Significance of P2RY12 in Antithrombotic-Treated STEMI – JTH
-
Jun 4, 2026, 12:43Beth Wallace: Raising Awareness of Hereditary Haemochromatosis
-
Jun 4, 2026, 11:57José María Bastida Bermejo: IPDs Help to Better Understand Platelet Biogenesis and Function
-
Jun 4, 2026, 11:07Cristina Pecorilla: PSG6 and A New Approach to Cancer-Associated Thrombosis